EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMBINANT INTERFERON AND BETAMETHASONE IN THE TREATMENT OF HAY FEVER DURING PERIODS OF EXACERBATION

Objective: to assess the efficacy, safety and tolerability of the new combined medication Allergoferon® beta in patients with moderate-to-severe hay fever (seasonal allergic rhinitis and conjunctivitis) during periods of exacerbation. patients and methods: the object of our study was medication Alle...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: A. A. Ryabtseva, N. Y. Sotnikova, O. V. Chumikov, N. A. Stupakova
Formato: Artigo
Idioma:Russo
Publicado: Ophthalmology Publishing Group 2016-09-01
Series:Oftalʹmologiâ
Assuntos:
hay fever
efficacy
safety
recombinant interferon
betamethasone
allergoferon® beta
Acceso en liña:https://www.ophthalmojournal.com/opht/article/view/324
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares